The risk or severity of adverse effects can be increased when Mirtazapine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Dronedarone. The serum concentration of Atorvastatin can be increased when it is combined with Ribociclib. The serum concentration of Atorvastatin can be increased when it is combined with Omapatrilat. The risk or severity of adverse effects can be increased when Cerivastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Vincristine is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Glibornuride. Colchicine may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Thiopental is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Methadone is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Gliquidone. The serum concentration of Thioridazine can be increased when it is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Bosentan. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Cimetidine. The serum concentration of Metoprolol can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nimodipine is combined with Atorvastatin. The serum concentration of Dabigatran etexilate can be decreased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Clemastine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tetracycline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Pinaverium is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ziprasidone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lercanidipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Bexarotene. The risk or severity of adverse effects can be increased when Pergolide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ethanol is combined with Atorvastatin. The serum concentration of Verapamil can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Azimilide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ecabet. The serum concentration of Atorvastatin can be increased when it is combined with Simeprevir. The risk or severity of adverse effects can be increased when Ezetimibe is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Boceprevir. The serum concentration of Atorvastatin can be decreased when it is combined with Deferasirox. The serum concentration of Ibrutinib can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tramadol is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Acetohexamide. The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Teniposide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Pazopanib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Cholesterol. The serum concentration of Atorvastatin can be increased when it is combined with Posaconazole. The serum concentration of Atorvastatin can be increased when it is combined with Telithromycin. The serum concentration of Atorvastatin can be increased when it is combined with 3,4-Dichloroisocoumarin. Atorvastatin may increase the hypoglycemic activities of Tolazamide. The serum concentration of Atorvastatin can be increased when it is combined with Aprotinin. The risk or severity of adverse effects can be increased when Tadalafil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fidaxomicin is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Aluminium. The risk or severity of adverse effects can be increased when Methylergometrine is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with St. John's Wort. The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Atorvastatin. The serum concentration of Mevastatin can be increased when it is combined with Atorvastatin. The serum concentration of Digoxin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fenofibrate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Metronidazole is combined with Atorvastatin. Gemfibrozil may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Rucaparib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Quinidine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Vildagliptin. The risk or severity of adverse effects can be increased when Tolfenamic Acid is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bepridil is combined with Atorvastatin. The serum concentration of Vincristine can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Batimastat. The serum concentration of Atorvastatin can be increased when it is combined with Argatroban. The serum concentration of Atorvastatin can be increased when it is combined with Antithrombin III human. The serum concentration of Nintedanib can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Alpha-1-proteinase inhibitor. Atorvastatin may increase the hypoglycemic activities of Glisoxepide. The risk or severity of adverse effects can be increased when Sitaxentan is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Phenelzine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Losartan is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Tipranavir. The risk or severity of adverse effects can be increased when Cinnarizine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Betamethasone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Chymostatin. The risk or severity of adverse effects can be increased when Sulfamethoxazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Benzamidine. The risk or severity of adverse effects can be increased when Zafirlukast is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Rivaroxaban. The serum concentration of Atorvastatin can be decreased when it is combined with Almasilate. The risk or severity of adverse effects can be increased when Vinorelbine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Terconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Remikiren. The serum concentration of Atorvastatin can be decreased when it is combined with Colesevelam. The risk or severity of adverse effects can be increased when Nimesulide is combined with Atorvastatin. The serum concentration of Aripiprazole can be decreased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Imidapril. Bezafibrate may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Fosaprepitant is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Acetaminophen is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Carboxyamidotriazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Caspofungin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Efinaconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lisuride is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Tromethamine. The risk or severity of adverse effects can be increased when Butoconazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Spiramycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bortezomib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Atazanavir. The risk or severity of adverse effects can be increased when Nevirapine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Enalaprilat. The serum concentration of Edoxaban can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Atorvastatin. The serum concentration of Doxorubicin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Gabapentin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ciprofloxacin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Prednisolone is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Trimethoprim. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Rescinnamine. The risk or severity of adverse effects can be increased when Isoconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Isoflurophate. Atorvastatin may increase the anticoagulant activities of Phenprocoumon. The risk or severity of adverse effects can be increased when Luliconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Darunavir. The risk or severity of adverse effects can be increased when Cocaine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Paramethasone is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Tocilizumab. The risk or severity of adverse effects can be increased when Nifedipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Elbasvir is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Daptomycin. The risk or severity of adverse effects can be increased when Nisoldipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ergonovine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Paritaprevir. The serum concentration of Atorvastatin can be increased when it is combined with Cobicistat. The risk or severity of adverse effects can be increased when Xylometazoline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Felodipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxymetholone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Docetaxel is combined with Atorvastatin.